Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00455 TIANDA PHARMA
RT Nominal unchange0.265 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
HKD(K$)
%Chg
(Final to Final)
2022/12
HKD(K$)
2022/03
HKD(K$)
2021/03
HKD(K$)
2020/03
HKD(K$)
Investment Properties0--0000
Property, plant, equip. & others371,3465.364%352,442382,492324,350169,905
Land & other Lease Assets41,392-13.885%48,06650,59353,42940,689
Intangible Assets115,90713.552%102,074128,151131,054125,521
Interests in Asso. & JCEs0--0000
Other Non-current Assets44,43860.351%27,71325,46918,2183,189

573,0838.069%530,295586,705527,051339,305
Current Assets
2023/12 - Final
HKD(K$)
%Chg
(Final to Final)
2022/12
HKD(K$)
2022/03
HKD(K$)
2021/03
HKD(K$)
2020/03
HKD(K$)
Inventories65,14835.181%48,19374,89464,39348,374
Trade Receivables104,801-24.469%138,752141,744145,20991,365
Cash & Bank Balances162,442-52.262%340,277334,002234,985302,018
Other Current Assets11,817-61.820%30,95126,80614,05017,958
Assets Held for Sale0--00147,774134,102

344,208-38.333%558,173577,446606,410593,818
Current Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Final to Final)
2022/12
HKD(K$)
2022/03
HKD(K$)
2021/03
HKD(K$)
2020/03
HKD(K$)
Trade Payables106,01848.609%71,340105,17487,91228,797
S-T Debt & Leases102,17045.326%70,30461,86223,0724,939
Other Current Liabilities105,124-52.385%220,781104,62388,48797,670
Liab asso w/ Assets Held for Sale0--0014,76413,592

313,312-13.551%362,425271,659214,234144,998
Net Current Assets30,896-84.216%195,748305,787392,176448,820
Total Assets Less Current Liabilities603,979-16.812%726,043892,492919,227788,124
Non-current Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Final to Final)
2022/12
HKD(K$)
2022/03
HKD(K$)
2021/03
HKD(K$)
2020/03
HKD(K$)
L-T Debt & Leases11,427-83.848%70,74698,571122,45820,294
Other Non-current Liabilities611-42.085%1,0554,8466,2748,067

12,038-83.234%71,801103,417128,73228,361
Capital and Reserves
2023/12 - Final
HKD(K$)
%Chg
(Final to Final)
2022/12
HKD(K$)
2022/03
HKD(K$)
2021/03
HKD(K$)
2020/03
HKD(K$)
  Share Capital215,0040.000%215,004215,004215,004215,004
  Reserves377,067-8.662%412,827541,750541,704507,772
  Others0--0000
Shareholders' Funds592,071-5.696%627,831756,754756,709722,777
Non-controlling Interests(130)--26,41132,32133,78636,986
Others0--0000

591,941-9.523%654,242789,075790,495759,763
Commitments and Contingent Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Final to Final)
2022/12
HKD(K$)
2022/03
HKD(K$)
2021/03
HKD(K$)
2020/03
HKD(K$)
Commitments64,750-25.132%86,48579,843100,410133,076
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 22/07/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders ($)HKD -24,155,000
%Change-41.052%
EPS / (LPS)HKD -0.011
NBV Per Share ($)HKD 0.275
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.